99 Results

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Riely
    Riely
  4. Giralt
    Giralt
  5. Abou-Alfa
    Abou-Alfa
  6. Ginsberg
    Ginsberg
  7. Kris
    Kris
  8. Postow
    Postow
  9. Shah
    Shah
  10. Tallman
    Tallman

Groups

  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)
  7. Epidemiology and Biostatistics (16)
  8. Thoracic Oncology (16)
  9. GSK Faculty (15)
  10. Biostatistics Service (13)
  1. "hypertransaminasemia"
Formats
  1. Journal Article (87)
  2. Review (10)
  3. Guidelines (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (78)
  2. Solid Tumor Oncology Division (53)
  3. Hematologic Malignancies, Division of (32)
  4. Center for Hematologic Malignancies (25)
  5. Survivorship Research (20)
  6. Radiology, Department of (17)

More Groups

People
  1. Martin Tallman (7)
  2. Alexander Drilon (6)
  3. Gregory Riely (6)
  4. Robert Motzer (6)
  5. Sergio Giralt (5)
  6. Ghassan Abou-Alfa (4)

More People

Years
  1. 2025 (9)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (10)
  5. 2021 (4)
  6. 2020 (12)

More Years

Publications
  1. Lancet Oncology (5)
  2. Leukemia and Lymphoma (5)
  3. New England Journal of Medicine (4)
  4. Annals of Oncology (3)
  5. Annals of Surgical Oncology (3)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Springer (10)
  3. Nature Publishing Group (9)
  4. Taylor & Francis Group (9)
  5. Elsevier Science, Inc. (7)
  6. Oxford University Press (6)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of neoadjuvant chemoimmunotherapy on surgical outcomes and time to radiation in triple-negative breast cancer
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Jones, V. M.; Abuhadra, N.; Montagna, G.; Plitas, G.; Morrow, M.; Downs-Canner, S. M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: Phase 1 trial interim results
    Journal Article

    Rappaport, A. R.; Kyi, C.; Lane, M.; Hart, M. G.; Johnson, M. L.; Henick, B. S.; Liao, C. Y.; Mahipal, A.; Shergill, A.; Spira, A. I.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • BRAF — A tumour-agnostic drug target with lineage-specific dependencies
    Review

    Hanrahan, A. J.; Chen, Z.; Rosen, N.; Solit, D. B.
    Nature Reviews Clinical Oncology (2024)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events
    Review

    Gu, S. L.; Nath, S.; Markova, A.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
    Journal Article

    Monje, M.; Cooney, T.; Glod, J.; Huang, J.; Peer, C. J.; Faury, D.; Baxter, P.; Kramer, K.; Lenzen, A.; Robison, N. J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Artificial intelligence and radiomics: Clinical applications for patients with advanced melanoma treated with immunotherapy
    Review

    McGale, J.; Hama, J.; Yeh, R.; Vercellino, L.; Sun, R.; Lopci, E.; Ammari, S.; Dercle, L.
    Diagnostics (2023)

    Fulltext@MSK | Save
  • Short report of a phase ii trial of nintedanib in recurrent malignant pleural mesothelioma (MPM)
    Journal Article

    Wozniak, A. J.; Schneider, B.; Kalemkerian, G. P.; Daly, B.; Chen, W.; Ventimiglia, J.; Nagasaka, M.; Zauderer, M. G.
    Clinical Lung Cancer (2023)

    Fulltext@MSK | Save
  • A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma
    Journal Article

    Merrill, M. H.; Dahi, P. B.; Redd, R. A.; McDonough, M. M.; Chen, Y. B.; DeFilipp, Z.; Herrera, A. F.; Fisher, D. C.; LaCasce, A. S.; Odejide, O. O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
    Journal Article

    Heumann, T.; Judkins, C.; Li, K.; Lim, S. J.; Hoare, J.; Parkinson, R.; Cao, H.; Zhang, T.; Gai, J.; Celiker, B.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save